Evidence map›Paper›PMID 25837582›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations.

Laurianne Van Landeghem, M Agostina Santoro, Amanda T Mah, Adrienne E Krebs, Jeffrey J Dehmer, Kirk K McNaughton, Michael A Helmrath, Scott T Magness, P Kay Lund

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. LeprCell research · 2022
    Article
  8. Article
  9. Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells.Cellular and molecular gastroenterology and hepatology · 2022
    Article
  10. Review
  11. Establishment of Intestinal Organoid fromInternational journal of molecular sciences · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Engineered Plant-Based Nanocellulose Hydrogel for Small Intestinal Organoid Growth.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Laurianne Van Landeghem*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
M Agostina Santoro*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
Amanda T Mah*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
Adrienne E Krebs*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
Jeffrey J Dehmer*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
Kirk K McNaughton*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
Michael A Helmrath*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
Scott T Magness*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA.
P Kay Lund*Department of Cell Biology and Physiology, Department of Nutrition, Department of Surgery, and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA; and University of North Carolina/North Carolina State Biomedical Engineering, Chapel Hill, North Carolina, USA empk@med.unc.edu.
University of North Carolina at Chapel Hill · USNorth Carolina State University · USUniversity of Cincinnati · US

Funding

PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
INTESTINAL ADAPTATION-ROLE OF HORMONES &GROWTH FACTORSR01DK040247 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DING, SHENGLI · 1989 to 2014
$4.5M
Genetic Control of Intestinal Epithelial Stem Cell Maintenance & DifferentiationR01DK091427 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAGNESS, SCOTT T · 2011 to 2015
$1.6M
Aging Intestinal Stem Cells and Insulin/IGF SystemR01AG041198 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DING, SHENGLI · 2012 to 2016
$1.5M
Intestinal Stem/progenitor Cell Potency and CompetenceK01DK080181 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAGNESS, SCOTT T · 2008 to 2010
$435k
SOX9, Enteroendocrine & Intestinal Epithelial Stem Cells in the intestinal cryptR03DK089126 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAGNESS, SCOTT T · 2010 to 2011
$147k
NCI NIH HHS P30-CA06086NIA NIH HHS R01 AG041198NIA NIH HHS R01-AG041198-01NIDDK NIH HHS K01 DK080181NIDDK NIH HHS P30 DK034987NIDDK NIH HHS P30-DK034987NIDDK NIH HHS R01 DK040247NIDDK NIH HHS R01-DK040247-19NIDDK NIH HHS R01 DK091427NIDDK NIH HHS R01-DK091427NIDDK NIH HHS R03 DK089126NIDDK NIH HHS R03-DK089126
6 · The paper itself

Abstract

Insulin-like growth factor 1 (IGF1) has potent trophic effects on normal or injured intestinal epithelium, but specific effects on intestinal stem cells (ISCs) are undefined. We used Sox9-enhanced green fluorescent protein (EGFP) reporter mice that permit analyses of both actively cycling ISCs (Sox9-EGFP(Low)) and reserve/facultative ISCs (Sox9-EGFP(High)) to study IGF1 action on ISCs in normal intestine or during crypt regeneration after high-dose radiation-induced injury. We hypothesized that IGF1 differentially regulates proliferation and gene expression in actively cycling and reserve/facultative ISCs. IGF1 was delivered for 5 days using subcutaneously implanted mini-pumps in uninjured mice or after 14 Gy abdominal radiation. ISC numbers, proliferation, and transcriptome were assessed. IGF1 increased epithelial growth in nonirradiated mice and enhanced crypt regeneration after radiation. In uninjured and regenerating intestines, IGF1 increased total numbers of Sox9-EGFP(Low) ISCs and percentage of these cells in M-phase. IGF1 increased percentages of Sox9-EGFP(High) ISCs in S-phase but did not expand this population. Microarray revealed that IGF1 activated distinct gene expression signatures in the 2 Sox9-EGFP ISC populations. In vitro IGF1 enhanced enteroid formation by Sox9-EGFP(High) facultative ISCs but not Sox9-EGFP(Low) actively cycling ISCs. Our data provide new evidence that IGF1 activates 2 ISC populations via distinct regulatory pathways to promote growth of normal intestinal epithelium and crypt regeneration after irradiation.

Indexed as

Adult Stem CellsAnimalsCell CycleGreen Fluorescent ProteinsInsulin-Like Growth Factor IIntestinal MucosaIntestine, SmallMiceMice, TransgenicMultipotent Stem CellsRadiation Injuries, ExperimentalReceptor, IGF Type 1Recombinant Fusion ProteinsRegenerationRNA, MessengerSOX9 Transcription Factorenhanced green fluorescent proteinGreen Fluorescent Proteinsinsulin-like growth factor-1, mouseInsulin-Like Growth Factor IReceptor, IGF Type 1Recombinant Fusion ProteinsRNA, MessengerSox9 protein, mouseSOX9 Transcription Factoractively cycling ISCsfacultative/reserve ISCsirradiationtissue regeneration

Identifiers

PMID25837582
PMCPMC4478798
OpenAlexW2023111845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.